日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind

将高危代谢功能障碍相关性脂肪性肝炎的诊断率提高一倍——不让任何人掉队

Abdelgadir, Elamin; Alawadi, Fatheya; Rashid, Fauzia; Bashir, Alaaeldin; Schattenberg, Jörn M

Correction to: Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates

更正:在阿联酋,对未控制的2型糖尿病患者,在二甲双胍治疗中添加格列齐特缓释片所产生的成本后果

Farghaly, Mohamed; Cristeau, Olivier; Al Awadi, Fatheya; Al Dallal, Sara

Post-bariatric Hypoglycemia Management: A Gulf Cooperation Council Consensus Statement

减重手术后低血糖管理:海湾合作委员会共识声明

Abdelgadir, Elamin; Rashid, Fauzia; Al Awadi, Fatheya; Al Busaidi, Noor Badar; Alfaris, Nasreen; Al Hadad, Mohammed; Alkaabi, Juma; Al Kharusi, Amira; Al Ozairi, Ebaa; Alromaihi, Dalal; AlSaleh, Aseel; Bashier, Alaaeldin; Bhatti, Rahila; Elhag, Wahiba; le Roux, Carel W; Suliman, Sara G I

Prevalence of overweight and obesity in adults from the Middle East: A large-scale population-based study

中东成年人超重和肥胖患病率:一项基于人群的大规模研究

Abdelgadir, Elamin; Rashid, Fauzia; Bashier, Alaaeldin; Zidan, Marwan; McGowan, Barbara; Alawadi, Fatheya

Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes

表征2型糖尿病亚型的循环microRNA特征

Sulaiman, Fatima; Khyriem, Costerwell; Dsouza, Stafny; Abdul, Fatima; Alkhnbashi, Omer; Faraji, Hanan; Farooqi, Muhammad; Al Awadi, Fatheya; Hassanein, Mohammed; Ahmed, Fayha; Alsharhan, Mouza; Tawfik, Abdel Rahman; Khamis, Amar Hassan; Bayoumi, Riad

Physician self-reported factors driving clinical decision-making in management of patients with T2D and ASCVD/high risk of ASCVD across the middle East and Africa: a cross-sectional study

中东和非洲地区医生自述影响2型糖尿病合并动脉粥样硬化性心血管疾病/高危动脉粥样硬化性心血管疾病患者临床决策的因素:一项横断面研究

Salek, Sam; Sabbour, Hani; Alamuddin, Naji; Alawadi, Fatheya; Alkandari, Hessa; Almahmeed, Wael; Assaad-Khalil, Samir H; Ceyhan, Emel Mashaki; Haddad, Jihad; Lombard, Landman; Ngome, Mary; Malik, Rayaz A; Yadav, Gourav

Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes

对患有长期2型糖尿病的MASLD患者进行肝纤维化严重程度的无创评估

Khan, Farooq; Dsouza, Stafny; Khamis, Amar Hassan; Abdul, Fatima; Farooqi, Muhammad Hamed; Sulaiman, Fatima; Mulla, Fahad; Al Awadi, Fatheya; Hassanein, Mohammed; Bayoumi, Riad

Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East

提高心血管代谢疾病患者的治疗依从性并减少治疗惰性:来自中东的行动呼吁

Almahmeed, Wael; Alabadla, Zainab; Al Awadi, Fatheya; Alrohmaihi, Dalal; AlShamiri, Mostafa; Elbadawi, Hussein; El-Tamimi, Hassan; Elzouki, Abdel-Nasser; Farghaly, Mohamed; Hafidh, Khadija; Hassanein, Mohamed; Hamad, Adel Khalifa; Khunti, Kamlesh; Sabbour, Hani; Schutte, Aletta E

Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates

在阿联酋,对未控制的2型糖尿病患者,在二甲双胍治疗中添加格列齐特缓释片的成本效益分析

Farghaly, Mohamed; Cristeau, Olivier; Al Awadi, Fatheya; Al Dallal, Sara

Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region

关于阿拉伯海湾地区2型糖尿病持续血糖监测的专家意见声明

Alshaikh, Abdulrahman; Bakhsh, Abdulmohsen; Al-Sagheir, Afaf; El-Laboudi, Ahmed; Al-Mohanadi, Dabia; Awadi, Fatheya Al; Elbadawi, Hussein; Alzubaidi, Lamya; Al-Sofiani, Mohammed E; Farooqi, Muhammad Hamed; Aldahash, Raed; Alamoudi, Reem; Alsifri, Saud; Almehthel, Mohammed